4.6 Article

Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric Patients

期刊

DIAGNOSTICS
卷 10, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/diagnostics10010021

关键词

pediatrics; laboratory; digital microfluidics; electrowetting; nanoliter; neonatal intensive care unit (NICU); bilirubin; glucose-6-phosphate dehydrogenase; albumin; thyroid; insulin; creatinine; cytomegalovirus

资金

  1. National Institute of Deafness and Communication Disorders (NIDCD) of the National Institutes of Health [R44DC016576]
  2. Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) of the National Institutes of Health [R44HD072853, R44HD095225, R44HD092154, R44HD093494]
  3. National Heart Blood and Lung (NHLBI) of the National Institutes of Health [R44HD093494, R44HL146016]

向作者/读者索取更多资源

Children are not tiny adults is an adage commonly used in pediatrics to emphasize the fact that children often have different physiological responses to sickness and trauma compared to adults. However, despite widespread acceptance of this concept, diagnostic blood testing is an excellent example of clinical care that is not yet customized to the needs of children, especially newborns. Cumulative blood loss resulting from clinical testing does not typically impact critically ill adult patients, but can quickly escalate in children, leading to iatrogenic anemia and related comorbidities. Moreover, the tests prioritized for rapid, near-patient testing in adults are not always the most clinically relevant tests for children or newborns. This report describes the development of a digital microfluidic testing platform and associated clinical assays purposely curated to address current shortcomings in pediatric laboratory testing by using microliter volumes (<50 mu L) of samples. The automated platform consists of a small instrument and single-use cartridges, which contain all reagents necessary to prepare the sample and perform the assay. Electrowetting technology is used to precisely manipulate nanoliter-sized droplets of samples and reagents inside the cartridge. To date, we have automated three disparate types of assays (biochemical assays, immunoassays, and molecular assays) on the platform and have developed over two dozen unique tests, each with important clinical application to newborns and pediatric patients. Cell lysis, plasma preparation, magnetic bead washing, thermocycling, incubation, and many other essential functions were all performed on the cartridge without any user intervention. The resulting assays demonstrate performance comparable to standard clinical laboratory assays and are economical due to the reduced hands-on effort required for each assay and lower overall reagent consumption. These capabilities allow a wide range of assays to be run simultaneously on the same cartridge using significantly reduced sample volumes with results in minutes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据